100 related articles for article (PubMed ID: 6318868)
21. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
22. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
23. Increased synthesis of extracellular spleen glycosaminoglycans in an experimental myeloproliferative syndrome.
Smadja-Joffe F; Moczar M; Le Bousse-Kerdiles C; Delpech B; Leibovitch MP; Dufour F; Jasmin C
Leukemia; 1992 Oct; 6(10):1011-9. PubMed ID: 1328775
[TBL] [Abstract][Full Text] [Related]
24. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
Wu DD; Nayar R; Keating A
Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic studies on myeloproliferative sarcoma virus (MPSV) induced leukemias and hemangiosarcoma in Jar-2 rats.
Hayashi Y; Tange T; Urano Y; Smadja-Joffe F; Le Bousse-Kerdiles MC; Jasmin C
Pathol Res Pract; 1988 Jun; 183(3):314-20. PubMed ID: 2458578
[TBL] [Abstract][Full Text] [Related]
27. An in vitro study of basophil production in chronic myeloproliferative disorders.
Piacibello W; Camussi G; Aglietta M
Exp Hematol; 1984 Nov; 12(10):759-62. PubMed ID: 6334609
[TBL] [Abstract][Full Text] [Related]
28. Detection of burst-promoting activity in spleens of myeloproliferative sarcoma virus-infected mice using serum-free cultures.
Matsuo K; Oda H; Fukushima T; Matsuoka J; Hashimoto N; Tadokoro K; Kohama H; Sato M; Jasmin C; Urano Y
Acta Pathol Jpn; 1991 Apr; 41(4):259-64. PubMed ID: 1862706
[TBL] [Abstract][Full Text] [Related]
29. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
[TBL] [Abstract][Full Text] [Related]
30. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
[TBL] [Abstract][Full Text] [Related]
31. Murine retrovirus-induced malignant histiocytosis, an experimental model for the disease in humans.
Löhler J; Franz T; Fusco A; Pragnell I; Ostertag W
Leukemia; 1987 Jan; 1(1):58-68. PubMed ID: 2823012
[TBL] [Abstract][Full Text] [Related]
32. Viral-associated alterations in hematopoiesis in the mouse.
Lobue J
Blood Cells; 1984; 10(2-3):211-22. PubMed ID: 6543651
[TBL] [Abstract][Full Text] [Related]
33. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
34. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
35. In vitro induction of CFU-S proliferation by a non viral splenic activity from myeloproliferative sarcoma virus infected mice.
Le Bousse-Kerdiles MC; Smadja-Joffe F; Bertoli AM; Comisso M; Mori KJ; Jasmin C
Leuk Res; 1985; 9(9):1181-8. PubMed ID: 2999521
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice.
Drutskaya MS; Ortiz M; Liepinsh DJ; Kuprash DV; Nedospasov SA; Keller JR
Exp Hematol; 2005 Nov; 33(11):1348-56. PubMed ID: 16263419
[TBL] [Abstract][Full Text] [Related]
37. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
[TBL] [Abstract][Full Text] [Related]
38. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
39. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
[TBL] [Abstract][Full Text] [Related]
40. TNF-alpha inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures.
Rogers JA; Berman JW
J Immunol; 1994 Nov; 153(10):4694-703. PubMed ID: 7963539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
